Pregnancy may increase the risk of adverse maternal and neonatal outcomes in SARS-CoV-
2 infection. Effectiveness of SARS-CoV-2 vaccines in pregnant women is not known. Using a …

Background SARS-CoV-2 infection in pregnancy is associated with a higher risk of
pregnancy-related complications and neonatal respiratory distress and hospitalization …

Objective Pregnancy is a risk factor for severe SARS-CoV-2 infection, which can result in
adverse pregnancy outcomes, thus making understanding vaccine effectiveness (VE) in this …

Despite a recent endorsement from official and professional bodies unequivocally
recommending COVID-19 vaccination, vaccine hesitancy among pregnant people remains …

Background Pregnant women are recommended to receive coronavirus disease 2019
(COVID-19) vaccines; however, relative effectiveness of vaccination by pregnancy status is …

The novel coronavirus, SARS‐CoV‐2, or COVID‐19, has affected the world on a pandemic
scale resulting in catastrophic outcomes and deaths. Currently, there is limited safety data …

BACKGROUND SARS-CoV-2 infection in pregnancy can result in a spectrum of
asymptomatic to critical COVID-19 outcomes, including hospitalization, admission to the …

Introduction. Sars-CoV-2 infection poses particular problems in pregnancy, as the infection
more frequently causes severe complications than in unaffected pregnant women or …

Background mRNA vaccination is an effective, safe, and widespread strategy for protecting
pregnant women against infection with severe acute respiratory syndrome coronavirus 2 …

Importance Data about the safety of vaccines against SARS-CoV-2 during pregnancy are
limited. Objective To examine the risk of adverse pregnancy outcomes after vaccination …